| A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib (NCT05599334) | Pierre Fabre Medicament | 2022-07-05 |
| U/S Guided Transversus Thoracic and Pectoral Nerve Block Versus Pectoral Nerve Block in MRM (NCT06371625) | Ahmed Mohamed Soliman | 2022-07-02 |
| Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast Cancer (NCT03872505) | Cedars-Sinai Medical Center | 2022-07-01 |
| Gut Microbiome Components Predict Response to Neoadjuvant Therapy in HER2-positive Breast Cancer Patients : A Prospective Study (NCT05444647) | The First Affiliated Hospital with Nanjing Medical University | 2022-07-01 |
| Investigation of the Effect of Education on Symptom Management on Symptom Management in Patients With Breast Cancer (NCT05393947) | Saglik Bilimleri Universitesi | 2022-07-01 |
| Chidamide in Combination With Abemaciclib and Endocrinotherapy（Doctor's Choice） in Breast Cancer Patients Previously Treated With Palbociclib (NCT05464173) | Biyun Wang, MD | 2022-07-01 |
| Topical Menthol Application in Chemotherapy-Related Peripheral Neuropathy in Patients With Breast Cancer (NCT05429814) | Necmettin Erbakan University | 2022-07-01 |
| Global Cardio Oncology Registry (NCT05598879) | The Cleveland Clinic | 2022-07-01 |
| Long-term Use of CCB and Breast Cancer Risk (NCT05972785) | Curtin University | 2022-07-01 |
| An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast Cancer (NCT05186545) | The First Affiliated Hospital of Zhengzhou University | 2022-07-01 |
| Association of Silicone Breast Implants With Overall Wellbeingand Auto-immune Diseases (NCT05400954) | The Netherlands Cancer Institute | 2022-07-01 |
| A Post Marketing Surveillance on Piqray in Korea (NCT05293470) | Novartis Pharmaceuticals | 2022-06-29 |
| Deformable Image Registration for Breast Adaptive Tomotherapy (NCT05383144) | Institut de cancérologie Strasbourg Europe | 2022-06-27 |
| Hypofractionated Radiotherapy in Breast Cancer Patients With Prosthetic Reconstruction (NCT05491395) | Barretos Cancer Hospital | 2022-06-27 |
| Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer. (NCT05378204) | Institut Claudius Regaud | 2022-06-23 |
| Comprehensive Outcomes for After Cancer Health (NCT05349227) | Pack Health | 2022-06-23 |
| Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O) (NCT05403177) | University Health Network, Toronto | 2022-06-23 |
| Efficacy and Safety of Non Invasive Vagal Stimulation to Prevent Chemotherapy-induced Nausea (NCT04937309) | University Hospital, Tours | 2022-06-23 |
| Respiratory Training and Relaxation Techniques to Improve Adjuvant Radiation Therapy in DIBH in Breast Cancer (NCT05975190) | Technical University of Munich | 2022-06-22 |
| CairnSurgical Breast Cancer Locator (BCL) Post-Market Study (NCT06461663) | CairnSurgical, Inc. | 2022-06-22 |
| Impact of Video Information Support on Preoperative Anxiety in Breast Cancer Surgery (NCT05350527) | University Hospital, Montpellier | 2022-06-22 |
| Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer (NCT04999917) | XEOS Medical | 2022-06-17 |
| Monitoring of Chronic Conditions in Breast Cancer (NCT05587777) | Helse Stavanger HF | 2022-06-15 |
| Sintilimab and Bevacizumab Biosimilar Combined With PLD in mTNBC (NCT05386524) | Fudan University | 2022-06-15 |
| Effectiveness of Cryotherapy Combined With Compression Therapy for Preventing Chemotherapy-induced Peripheral Neuropathy (NCT05341141) | Peking University | 2022-06-10 |
| To Check Safety of Ayurvedic Oral Cannabis in Breast and Head and Neck Cancer (NCT05969314) | Tata Memorial Hospital | 2022-06-08 |
| A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer (NCT05412225) | Memorial Sloan Kettering Cancer Center | 2022-06-06 |
| Immune Therapy in HR-positive/HER2-negative Metastatic Breast Cancer(ENIGMA)-BCTOP-L-M02 (NCT05205200) | Fudan University | 2022-06-06 |
| Communication in Breast Cancer Care (NCT05390723) | Leiden University | 2022-06-05 |
| Stress Management and Biological Age in Breast Cancer Patients.RCT (NCT05984914) | Maria Charalampopoulou | 2022-06-04 |
| Cognitive Stimulation and Chemobrain. An Innovative Intervention for Cancer Survivors (NCT05409248) | Universidad Antonio de Nebrija | 2022-06-03 |
| Cardiometabolic Screening Program (NCT05386719) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-06-03 |
| Increasing Access to Fertility Preservation for Women with Breast Cancer (NCT05989776) | University Paul Sabatier of Toulouse | 2022-06-01 |
| Postoperative Opt-In Narcotics Treatment in Breast (NCT05078398) | University of California, Los Angeles | 2022-06-01 |
| Feasibility and Metabolic Effects of a 5:2 Fasting Intervention in Women With Breast Cancer During Radiotherapy (NCT05861362) | MVZ Leopoldina GmbH | 2022-06-01 |
| Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy (NCT07127315) | Helwan University | 2022-06-01 |
| Effectiveness of Mobile Messenger-initiated Reminder on Biannual Mammography Adherence in Breast Cancer Screening (NCT05048641) | Chinese University of Hong Kong | 2022-06-01 |
| TOPAZ: Tucatinib in COmbination With Pembrolizumab And TrastuZumab in Patients With HER2-Positive Breast Cancer Brain Metastases (NCT04512261) | Reva Basho | 2022-06-01 |
| The Effect of Training Given by Mobile Application to Women Undergoing Breast Surgery (NCT04914780) | KTO Karatay University | 2022-06-01 |
| HER2-positive Breast Cancer Project Initiated by Investigators (NCT05346328) | Fudan University | 2022-06-01 |
| Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors (NCT05452681) | University of Alabama at Birmingham | 2022-06-01 |
| Breast Cancer Prevention and Screening Membership (NCT05258539) | Assistance Publique - Hôpitaux de Paris | 2022-05-31 |
| Assessment of Brain Cognitive Impairment in Breast Cancer (NCT05305092) | Tang-Du Hospital | 2022-05-31 |
| Psyco Quality of Life and Procreation BRCA1/2 (NCT05857670) | Regina Elena Cancer Institute | 2022-05-31 |
| FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors (NCT05395052) | Fate Therapeutics | 2022-05-31 |
| Pyrotinib Combined With Capecitabine in HER-2 Positive Advanced Breast Cancer and Brain Metastases (Post-PERMEATE) (NCT05359120) | Henan Cancer Hospital | 2022-05-30 |
| Outcomes Among Patients in Brazil Receiving Palbociclib Combinations for HR+/HER2- MBC (NCT05505175) | Pfizer | 2022-05-30 |
| Factors Influencing Breast Cancer Resection Volumes And Their Impact on Treatment Outcome (FIBRATIO) (NCT05257577) | Tampere University Hospital | 2022-05-28 |
| Prognostic Impact of the Neutrophil/Lymphocyte Ratio (NLR) in the Treatment of First-line Metastatic or Locally Advanced Breast Cancer Treated With CDK4/6 Inhibitor. (NCT05303129) | Centre Francois Baclesse | 2022-05-27 |
| CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer (NCT05251714) | Treadwell Therapeutics, Inc | 2022-05-27 |
| 3-D Super Resolution Ultrasound Microvascular Imaging (NCT04136912) | UNC Lineberger Comprehensive Cancer Center | 2022-05-26 |
| CIPN in Early Stage Breast Cancer Patients (NCT05441722) | Northumbria University | 2022-05-26 |
| Noninvasive Assessment of Lymphedema Among Breast Cancer Survivors (NCT05278871) | Microelastic Ultrasound Systems Inc | 2022-05-26 |
| A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer (NCT05433480) | Betta Pharmaceuticals Co., Ltd. | 2022-05-25 |
| Risk Prediction of Taxane Chemotherapy-Induced Peripheral Neuropathy (NCT04932031) | Sapere Bio | 2022-05-25 |
| A Phase Ib/II Study of SHR-A1811 Injection in Breast Cancer (NCT05353361) | Jiangsu HengRui Medicine Co., Ltd. | 2022-05-23 |
| Clinical Study of Chidamide Combined With Chemotherapy in Neoadjuvant Treatment of HR+/ HER2-BC (NCT05400993) | Shengjing Hospital | 2022-05-23 |
| Aerobic Training and Diet on the Immune System in Postmastectomy Patients Receiving Chemotherapy (NCT05605808) | Cairo University | 2022-05-20 |
| A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer or Other Solid Tumors (NCT05339685) | Sichuan Baili Pharmaceutical Co., Ltd. | 2022-05-20 |
| Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer. (NCT05817227) | National Cancer Institute, Naples | 2022-05-19 |
| Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients (NCT05396118) | Rigshospitalet, Denmark | 2022-05-18 |
| Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer (NCT05293964) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2022-05-18 |
| Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy (NCT05472792) | UNC Lineberger Comprehensive Cancer Center | 2022-05-17 |
| The Effects of a Nurse-led MHealth Program for Symptom Self-management of Breast Cancer Patients Undergoing Chemotherapy (NCT05192525) | The Hong Kong Polytechnic University | 2022-05-16 |
| Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer (NCT03936478) | University of Wisconsin, Madison | 2022-05-16 |
| A Pharmacokinetic Study Comparing EG1206A and Perjeta (Pertzumab) in Healthy Male Volunteers (NCT05471648) | EirGenix, Inc. | 2022-05-16 |
| A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02) (NCT05374512) | AstraZeneca | 2022-05-16 |
| The Effect of Self-compassion on Breast Cancer (NCT05240937) | University of Beykent | 2022-05-15 |
| Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision Aid (NCT05140252) | University of Michigan Rogel Cancer Center | 2022-05-12 |
| Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients (NCT05580887) | Moscow Clinical Scientific Center | 2022-05-12 |
| A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer (NCT05474690) | Henan Cancer Hospital | 2022-05-11 |
| Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors (NCT05311618) | NGM Biopharmaceuticals, Inc | 2022-05-11 |
| A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors (NCT05307705) | Eli Lilly and Company | 2022-05-11 |
| Lymphaticovenous Anastomosis as Treatment for Lymphedema (NCT05441943) | Odense University Hospital | 2022-05-11 |
| Characterizing Breast Cancer With Al18F-NOTA-FAPI-04 PET/CT (PFB-02) (NCT05574920) | Peking Union Medical College Hospital | 2022-05-10 |
| Antidepressant Efficacy of Psychotherapy and Citalopram in Patients With Breast Cancer and Major Depression (NCT05063604) | Hospital Universitari de Bellvitge | 2022-05-10 |
| The Unmet Needs and the Workplace Reintegration of Breast Cancer Patients: the NEW-BreCa Project (NCT05309252) | Azienda USL Reggio Emilia - IRCCS | 2022-05-09 |
| Handheld Ultrasound Device to Triage Women With a Positive Clinical Breast Examination by Trained Non-radiologists (NCT06056843) | International Agency for Research on Cancer | 2022-05-09 |
| LIMBO : Breast Reconstruction by Lipomodeling Alone or With Flap: Evaluation in Franche-Comté (NCT06101732) | Centre Hospitalier Universitaire de Besancon | 2022-05-05 |
| Intraoperative Evaluation of Axillary Lymphatics (NCT05094102) | University of Wisconsin, Madison | 2022-05-05 |
| Social Risk Factors and Discrimination in Cancer Survivorship (NCT05301114) | Medstar Health Research Institute | 2022-05-05 |
| Time Restricted Eating on Cancer Risk (NCT05038137) | Medical University of South Carolina | 2022-05-04 |
| cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (NCT05366881) | Adela, Inc | 2022-05-03 |
| Optimizing Postoperative Recovery After Breast Reconstruction With Autologous Tissue (BestDIEP) (NCT05363189) | Vastra Gotaland Region | 2022-05-02 |
| Mobile Health App to Promote Participation of Black Women in Breast Cancer Clinical Trials (NCT06361056) | UNC Lineberger Comprehensive Cancer Center | 2022-05-02 |
| Effect of Helmet Type, Home-use Low-level Light Therapy Device for Chemotherapy-induced Alopecia (NCT05397457) | Chang Gung Memorial Hospital | 2022-05-01 |
| The HIFUB Study (HIFU in Breast Cancer) (NCT05350059) | University of Oxford | 2022-05-01 |
| Screening Contralateral Breast Cancers in Patients With Newly Diagnosed Breast Cancer (NCT05307757) | Seoul National University Hospital | 2022-05-01 |
| Diffusion-Weighted MRI for Diagnosis of Multifocal, Multicentric Breast Cancer (NCT04656639) | Seoul National University Hospital | 2022-05-01 |
| AC vs TC in Patients With HR-positive, HER2-negative Early Breast Cancer (NCT05302336) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2022-05-01 |
| Relationship Between Breast Cancer Subtypes and Immune Checkpoints (NCT05460702) | Istanbul Training and Research Hospital | 2022-05-01 |
| Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen (NCT05731258) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2022-05-01 |
| 99mTc-ADAPT6 SPECT-based Non-invasive Quantification of HER2-expression in Breast Cancer With Metastatic Lymph Nodes (NCT05412446) | Tomsk National Research Medical Center of the Russian Academy of Sciences | 2022-05-01 |
| The Effect of the Motivational Interviewing Technique on Breast and Cervical Cancer Screenings (NCT05353387) | Istanbul Saglik Bilimleri University | 2022-04-30 |
| Utidelone Plus Bevacizumab for Advanced Breast Cancer With Brain Metastases (NCT05357417) | Henan Cancer Hospital | 2022-04-29 |
| Mini-invasive Detection of Residual Disease in Breast Cancer Patients in Remission After Primary Chemotherapy (NCT05951699) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2022-04-28 |
| Mapping Arterial Perforators Within the Breast During Mammoplasty (NCT06347952) | Royal Marsden NHS Foundation Trust | 2022-04-27 |
| Identifying Prognostic Variables for Persistent Upper Limb Dysfunctions After Breast Cancer Treatment (NCT05297591) | KU Leuven | 2022-04-26 |
| Identifying Prognostic Variables for Persistent UL Dysfunctions After Breast Cancer Treatment -Reliability and Validity (NCT05371847) | KU Leuven | 2022-04-26 |
| A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer (NCT05346224) | Shanghai Henlius Biotech | 2022-04-25 |